AbbVie
ABBV
#27
Rank
โ‚น43.835 T
Marketcap
โ‚น24,811
Share price
1.43%
Change (1 day)
50.65%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น533.26 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น62.81 Billion. In 2025 the company made an earning of โ‚น637.07 Billion, an increase over its 2024 earnings that were of โ‚น358.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น533.26 B-16.29%
2025 โ‚น637.07 B77.53%
2024 โ‚น358.85 B-40.54%
2023 โ‚น603.56 B-53.62%
2022 โ‚น1.301 T3.76%
2021 โ‚น1.254 T282.25%
2020 โ‚น328.14 B-59.67%
2019 โ‚น813.69 B62.13%
2018 โ‚น501.87 B-32.74%
2017 โ‚น746.19 B-1.99%
2016 โ‚น761.35 B18.65%
2015 โ‚น641.70 B180.5%
2014 โ‚น228.77 B-55.57%
2013 โ‚น514.91 B-6.86%
2012 โ‚น552.85 B56.05%
2011 โ‚น354.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.022 T 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.005 T 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น877.53 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น156.73 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.036 T 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น926.78 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.416 T 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น966.80 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น77.14 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA